======= NPIPB3 ======= == Gene Information == * **Official Symbol**: NPIPB3 * **Official Name**: nuclear pore complex interacting protein family member B3 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=23117|23117]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q92617|Q92617]] * **Interactions**: [[https://thebiogrid.org/search.php?search=NPIPB3&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20NPIPB3|Open PubMed]] * **OMIM**: [[https://omim.org/entry/619984|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: N/A |NPIP| |molecular function| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp20|Etoposide 10μM R00 exp20]]|-2.1| |[[:results:exp66|BI-D1870 3.15μM R02 exp66]]|-2.02| |[[:results:exp399|Salubrinal 20μM R07 exp399]]|-1.96| |[[:results:exp199|Etoposide 0.3μM R05 exp199]]|-1.95| |[[:results:exp343|Centrinone 0.5μM R07 exp343]]|1.73| |[[:results:exp280|Daidzin 10μM R06 exp280]]|1.75| |[[:results:exp14|Cycloheximide 0.02μM R00 exp14]]|1.79| |[[:results:exp335|Aminopterin 0.005μM R07 exp335]]|1.8| |[[:results:exp270|Campthothecin 0.001μM R06 exp270]]|1.8| |[[:results:exp291|LLY-284 2.6μM R06 exp291]]|1.8| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|1.81| |[[:results:exp277|Curcumin 6.5μM R06 exp277]]|1.84| |[[:results:exp23|Nocodazole 0.02μM R00 exp23]]|1.88| |[[:results:exp217|Mdivi-1 15μM R05 exp217]]|1.95| |[[:results:exp18|Doxycycline 10μM R00 exp18]]|1.96| |[[:results:exp372|Ibrutinib 1μM R07 exp372]]|1.97| |[[:results:exp316|Geldanamycin 0.015 to 0.025μM on day4 R07 exp316]]|2| |[[:results:exp113|1-Methyl-nicotinamide-chloride 1000μM R03 exp113]]|2.02| |[[:results:exp359|FK-506 30μM R07 exp359]]|2.05| |[[:results:exp78|Pterostilbene 16μM R02 exp78]]|2.05| |[[:results:exp300|VE-822 0.04μM R06 exp300]]|2.08| |[[:results:exp330|5-Azacytidine 2μM R07 exp330]]|2.14| |[[:results:exp103|Taxol 0.004μM R03 exp103]]|2.17| |[[:results:exp11|CCCP 1μM R00 exp11]]|2.44| |[[:results:exp150|SGC0649 7μM R03 exp150]]|2.44| |[[:results:exp16|DABN 2μM R00 exp16]]|2.46| |[[:results:exp149|SB203580 25μM R03 exp149]]|2.48| |[[:results:exp164|Q15 1 to 2μM on day4 R04 exp164]]|2.52| |[[:results:exp375|Lenalidomide 20μM R07 exp375]]|2.61| |[[:results:exp38|Wortmannin 5μM R00 exp38]]|2.66| |[[:results:exp393|Resminostat 0.5μM R07 exp393]]|2.77| |[[:results:exp298|Sucrose 20000μM R06 exp298]]|3.81| ^Gene^Correlation^ |[[:human genes:g:golga6l1|GOLGA6L1]]|0.7| |[[:human genes:s:snrpa1|SNRPA1]]|0.457| |[[:human genes:r:rps9|RPS9]]|0.429| |[[:human genes:p:plekha4|PLEKHA4]]|0.422| |[[:human genes:c:copb1|COPB1]]|0.408| Global Fraction of Cell Lines Where Essential: N/A ^Tissue^Fraction Of Cell Lines Where Essential^ == Essentiality in NALM6 == * **Essentiality Rank**: 1390 * **Expression level (log2 read counts)**: 6.36 {{:chemogenomics:nalm6 dist.png?nolink |}}